Evidence map›Paper›PMID 38899928›Full record

ArticleAntimicrobial agents and chemotherapy2024

Alberto Antonelli, Marco Coppi, Chiara Bonaiuto, Nicla Giovacchini, Camilla Grifoni, Guendalina Vaggelli, Roberto Pupillo, Federica Vannetti, Alberto Farese, Bruno Viaggi and 2 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alberto Antonelli *Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0003-0295-6877
Marco Coppi *Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Chiara BonaiutoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Nicla GiovacchiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Camilla GrifoniNARR Joint Laboratory for Antimicrobial Resistance Research and Control, University of Florence-IRCCS Don Gnocchi Foundation, Florence, Italy.
Guendalina VaggelliMicrobiology and Virology Unit, Careggi University Hospital, Florence, Italy.
Roberto PupilloMedical Direction, IRCCS Don Gnocchi Foundation, Florence, Italy.
Federica VannettiMedical Direction, IRCCS Don Gnocchi Foundation, Florence, Italy.
Alberto FareseInfectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Bruno ViaggiIntensive Care Unit for Neurological Injuries, Careggi University Hospital, Florence, Italy.
Simona PolliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Gian Maria RossoliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0002-9386-0434

Funding

Ministero della Salute (Italy Ministry of Health) PAN-HUB 2021Ministero dell'Università e della Ricerca (MUR) PRIN 2022WBPFSC
6 · The paper itself

Abstract

FIM-1 metallo-β-lactamase was previously detected in sporadic

Indexed as

Anti-Bacterial Agentsbeta-LactamasesPseudomonas aeruginosaPseudomonas InfectionsWhole Genome SequencingCross InfectionHospitals, RehabilitationHumansMaleMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-Lactamasesclass B carbapenemaseICEP. aeruginosaST235

Identifiers

PMID38899928
PMCPMC11232380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.